Allogenic MHC-wild-type artery grafts maintain 100% patency in a rhesus model. Credit: Cell Reports Medicine (2025). DOI: 10.1016/j.xcrm.2025.102002 ...

Global Man made Vascular Graft Market Size was estimated at USD 3430.67 million in 2021 and is projected to reach USD 5042.41 million by 2028, exhibiting a CAGR of 5.66% during the forecast period.

Background—Long-term patency of conventional synthetic grafts is unsatisfactory below a 6-mm internal diameter. Poly(ε-caprolactone) (PCL) is a promising biodegradable polymer with a longer ...

Angiotech now has the exclusive rights to distribute the Vascular Wrap(TM)/ePTFE graft combination product through its own sales force and distribution network in Europe. Edwards still retains the ...

Angiotech Pharmaceuticals, Inc. to Market Vascular Wrap(TM)/ePTFE Graft Combination Product Through its Own European Sales and Distribution Networks ...

The GORE PROPATEN Vascular Graft is the first ePTFE vascular graft that reduces thrombosis 1 — or clotting — and is designed to address the clinical problem of thrombotic vascular graft failure.